Peeling Skin Syndrome Type 1: Dupilumab Reduces IgE, But Not Skin Anomalies

J Clin Immunol. 2022 May;42(4):873-875. doi: 10.1007/s10875-021-01194-1. Epub 2022 Feb 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Dermatitis, Exfoliative*
  • Humans
  • Immunoglobulin E
  • Skin
  • Skin Diseases, Genetic

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunoglobulin E
  • dupilumab

Supplementary concepts

  • Peeling Skin Syndrome